George Y. Liu, MD, PhD
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Languages
- English,
Gender
Male
Experience
25 Years
Locations
Los Angeles
34.0749961 -118.3805638Los Angeles
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- Peds - Infectious Disease
Programs
Titles
- Director, Infectious & Immunological Diseases Research Center
- Associate Professor, Pediatrics
Education & Training
-
University of California San Diego Medical Center
Fellowship - Completed 2006
-
University of California Davis Medical Center
Residency - Completed 2001
-
University of California San Diego School of Medicine
Medical School - Completed 1998
-
University of Cambridge
Degrees - Completed 1995
-
California Institute of Technology
Degrees - Completed 1990
Achievements
-
1
Board Certifications
-
5
Awards and Honors
Board Certifications
-
Peds - Infectious Disease
American Board of Pediatrics
Awards and Honors
- American Society for Clinical Investigation (Elected)
- Pediatric Infectious Disease Society Young Investigator Award
- Howard Hughes Medical Institute Postdoctoral Fellowship
- Burroughs Wellcome Career Award in Biomedical Sciences
- ASM Merck Irving S. Sigal Memorial Award
Publications
- Sanchez M, Kolar SL, Muller S, Reyes CN, Wolf AJ, Ogawa C, deCarvalho D, Arditi M, Underhill DM, Martins GA, Liu GY. O-acetylation of peptidoglycan limits helper T cell priming and permits Staphylococcus aureus reinfection. Cell Host Microbe. 2017;22:543-551.
- Kolar S, Kyme P, Tseng CW, Soliman A, Kaplan A, Liang J, Nizet V, Jiang D, Murali R, Arditi M, Underhill DM, Liu GY. Group B Streptococcus evades host immunity by degrading hyaluronan. Cell Host Microbe. 2015;18:694-704.
- Kyme P, Thoennissen NH, Tseng CW, Iwanski GB, Shimada K, Krug UO, Lee K, Hardy WD, Gombart AF, Koeffler HP, Liu GY. CCAAT/enhancer binding protein epsilon mediates nicotinamide-enhanced clearance of Staphylococcus aureus infection. J Clin Invest. 2012;122:3316-3329.
- Liu C*, Liu GY*, Song Y, Yin F, Hensler ME, Nizet V, Wang AH, Oldfield E. A cholesterol lowering drug inhibits Staphylococcus aureus virulence. Science. 2008;319:391-394 (*Co-first authors).
- Sabrina Müller, Wolf AJ, Iliev ID, Berg BL, Underhill DM, and Liu GY. Poorly cross-linked peptidoglycan formed in MRSA due to mecA induction strongly activates the NLRP3 inflammasome and exacerbates immunopathology. Cell Host Microbe. 2015;18:604-612.
- Tseng CW, Biancotti JC, Berg BL, Gate D, Kolar SL, Muller S, Rodriguez MD, Rezai-Zadeh K, Fan X, Beenhouwer DO, Town T, Liu GY. Humanized mice are more susceptible to Staphylococcus aureus skin and soft tissue infection. PLoS Pathog. 2015;11:e1005292.